888-776-0942 from 8 AM - 10 PM ET
DUBLIN , Dec. 29, 2021 /PRNewswire/ -- The "Prefilled Devices for Self Administered High Viscosity Injectables" report has been added to ResearchAndMarkets.com's offering.
Prefilled Devices for Self-Administering High Viscosity Injectables: Technologies, Markets, Strategies and Forecasts is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector.
The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, opportunities for handheld injection devices that are capable of injecting drugs with high viscosities.
Provider organization business managers, healthcare administrators and investors will also benefit from this study.
Growth in self-administered high viscosity injectables is being driven by advances in biotechnology and host-vector engineering - advances that have led to a steady stream of biologics for a number of ailments and conditions.
These powerful drugs come with a high cost-per-dose and the risk of significant side effects - factors that place an elevated emphasis on administration efficiency, safety and reliability.
Many drugs in this class are characterized by physical properties and sensitivities that challenge the drug commercialization ecosystem.
For example, monoclonal antibodies, perhaps the most significant category in terms of therapeutic and commercial importance, typically possess viscosities that are well above the normal limits of subcutaneous injection devices and techniques.
Without a technical solution, these high viscosity drugs are formulated and supplied for infusion, a trend that threatens to put additional pressure on patient logistics and healthcare economics. Drug developers and device designers are increasingly working in collaboration to address the goal of subcutaneous administration of high viscosity injectables.
3. High Viscosity Injection Device Design Factors
4. High Viscosity Drugs - Addressable Markets
5. Analysis of Hi Viscosity Handheld Devices
For more information about this report visit https://www.researchandmarkets.com/r/h3gkmu
Research and Markets Laura Wood , Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
More news releases in similar topics
Cision Distribution 888-776-0942 from 8 AM - 9 PM ET